<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39468707</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2150-5608</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Virulence</Title><ISOAbbreviation>Virulence</ISOAbbreviation></Journal><ArticleTitle>The characteristics of TCR CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccine recipients.</ArticleTitle><Pagination><StartPage>2421987</StartPage><MedlinePgn>2421987</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2421987</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/21505594.2024.2421987</ELocationID><Abstract><AbstractText>The COVID-19 pandemic and large-scale administration of multiple SARS-CoV-2 vaccines have attracted global attention to the short-term and long-term effects on the human immune system. An analysis of the "traces" left by the body's T-cell immune response is needed, especially for the prevention and treatment of breakthrough infections and long COVID-19 and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant infections. T-cell receptor complementarity determining region 3 (TCR CDR3) repertoire serves as a target molecule for monitoring the effects, mechanisms, and memory of the T-cell response. Furthermore, it has been extensively applied in the elucidation of the infectious mechanism and vaccine refinement of hepatitis B virus (HBV), influenza virus, human immunodeficiency virus (HIV), and SARS-CoV. Laboratories worldwide have utilized high-throughput sequencing (HTS) and scTCR-seq to characterize, share, and apply the TCR CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccine recipients. This article focuses on the comparative analysis of the diversity, clonality, V&amp;J gene usage and pairing, CDR3 length, shared CDR3 sequences or motifs, and other characteristics of TCR CDR3 repertoire. These findings provide molecular targets for evaluating T-cell response effects and short-term and long-term impacts on the adaptive immune system following SARS-CoV-2 infection or vaccination and establish a comparative archive of T-cell response "traces."</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Dewei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Immunology, Center of Immunomolecular Engineering, Innovation &amp; Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Immunology, Center of Immunomolecular Engineering, Innovation &amp; Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Qingqing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Central Laboratory, Guizhou Aerospace Hospital, Zunyi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Immunology, Center of Immunomolecular Engineering, Innovation &amp; Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Xinsheng</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-6960-4003</Identifier><AffiliationInfo><Affiliation>Department of Immunology, Center of Immunomolecular Engineering, Innovation &amp; Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Virulence</MedlineTA><NlmUniqueID>101531386</NlmUniqueID><ISSNLinking>2150-5594</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022801">Complementarity Determining Regions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011948">Receptors, Antigen, T-Cell</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022801" MajorTopicYN="Y">Complementarity Determining Regions</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011948" MajorTopicYN="Y">Receptors, Antigen, T-Cell</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 vaccine</Keyword><Keyword MajorTopicYN="N">TCR CDR3 repertoire</Keyword><Keyword MajorTopicYN="N">high-throughput sequencing</Keyword><Keyword MajorTopicYN="N">single-cell TCR sequencing</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>1</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39468707</ArticleId><ArticleId IdType="doi">10.1080/21505594.2024.2421987</ArticleId><ArticleId IdType="pmc">PMC11540089</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cui J, Li F, Shi Z-L.. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181&#x2013;9. doi: 10.1038/s41579-018-0118-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0118-9</ArticleId><ArticleId IdType="pmc">PMC7097006</ArticleId><ArticleId IdType="pubmed">30531947</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarke A, Sidney J, Kidd CK, et al. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Rep Med. 2021;2(2):100204. doi: 10.1016/j.xcrm.2021.100204</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100204</ArticleId><ArticleId IdType="pmc">PMC7837622</ArticleId><ArticleId IdType="pubmed">33521695</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadarangani M, Marchant A, Kollmann TR. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat Rev Immunol. 2021;21(8):475&#x2013;484. doi: 10.1038/s41577-021-00578-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00578-z</ArticleId><ArticleId IdType="pmc">PMC8246128</ArticleId><ArticleId IdType="pubmed">34211186</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng G, Yin M, Chen X, et al. Clinical determinants for fatality of 44,672 patients with COVID-19. Crit Care. 2020;24(1):179. doi: 10.1186/s13054-020-02902-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02902-w</ArticleId><ArticleId IdType="pmc">PMC7187660</ArticleId><ArticleId IdType="pubmed">32345311</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift AK, Coupland CAC, Keogh RH, et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ. 2020;371:m3731. doi: 10.1136/bmj.m3731</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3731</ArticleId><ArticleId IdType="pmc">PMC7574532</ArticleId><ArticleId IdType="pubmed">33082154</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Dong X, Liu G, et al. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clinic Rev Allerg Immunol. 2023;64(1):90&#x2013;107. doi: 10.1007/s12016-022-08921-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-022-08921-5</ArticleId><ArticleId IdType="pmc">PMC8767775</ArticleId><ArticleId IdType="pubmed">35044620</ArticleId></ArticleIdList></Reference><Reference><Citation>Combes AJ, Courau T, Kuhn NF, et al. Global absence and targeting of protective immune states in severe COVID-19. Nature. 2021;591(7848):124&#x2013;130. doi: 10.1038/s41586-021-03234-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03234-7</ArticleId><ArticleId IdType="pmc">PMC8567458</ArticleId><ArticleId IdType="pubmed">33494096</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin U, Muik A, Vogler I, et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021;595(7868):572&#x2013;577. doi: 10.1038/s41586-021-03653-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03653-6</ArticleId><ArticleId IdType="pubmed">34044428</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M, Gao Y, Wang G, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17(5):533&#x2013;535. doi: 10.1038/s41423-020-0402-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0402-2</ArticleId><ArticleId IdType="pmc">PMC7091858</ArticleId><ArticleId IdType="pubmed">32203188</ArticleId></ArticleIdList></Reference><Reference><Citation>Rydyznski Moderbacher C, Ramirez SI, Dan JM, et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell. 2020;183(4):996&#x2013;1012.e19. doi: 10.1016/j.cell.2020.09.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.038</ArticleId><ArticleId IdType="pmc">PMC7494270</ArticleId><ArticleId IdType="pubmed">33010815</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Wang G, Wang Y, et al. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study. Lancet Microbe. 2022;3(5):e348&#x2013;e356. doi: 10.1016/S2666-5247(22)00036-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(22)00036-2</ArticleId><ArticleId IdType="pmc">PMC8942480</ArticleId><ArticleId IdType="pubmed">35345417</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed SF, Quadeer AA, McKay MR. Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses. 2020;12(3):254. doi: 10.3390/v12030254</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12030254</ArticleId><ArticleId IdType="pmc">PMC7150947</ArticleId><ArticleId IdType="pubmed">32106567</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bert N, Tan AT, Kunasegaran K, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020;584(7821):457&#x2013;462. doi: 10.1038/s41586-020-2550-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2550-z</ArticleId><ArticleId IdType="pubmed">32668444</ArticleId></ArticleIdList></Reference><Reference><Citation>Laydon DJ, Bangham CRM, Asquith B. Estimating T-cell repertoire diversity: limitations of classical estimators and a new approach. Phil Trans R Soc B. 2015;370(1675):20140291. doi: 10.1098/rstb.2014.0291</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2014.0291</ArticleId><ArticleId IdType="pmc">PMC4528489</ArticleId><ArticleId IdType="pubmed">26150657</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Li J, Shi B, et al. T cell receptor (TCR) repertoire and common analytical tools for high-throughput sequencing. Chin J Cell Mol Immunol. 2021;37(9):851&#x2013;857. doi: 10.13423/j.cnki.cjcmi.009279</Citation><ArticleIdList><ArticleId IdType="doi">10.13423/j.cnki.cjcmi.009279</ArticleId><ArticleId IdType="pubmed">34533132</ArticleId></ArticleIdList></Reference><Reference><Citation>Unterman A, Sumida TS, Nouri N, et al. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19. Nat Commun. 2022;13(1):440. doi: 10.1038/s41467-021-27716-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27716-4</ArticleId><ArticleId IdType="pmc">PMC8782894</ArticleId><ArticleId IdType="pubmed">35064122</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Jin X, Zhou W, et al. Comprehensive analysis of TCR repertoire in COVID-19 using single cell sequencing. Genomics. 2021;113(2):456&#x2013;462. doi: 10.1016/j.ygeno.2020.12.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2020.12.036</ArticleId><ArticleId IdType="pmc">PMC7833309</ArticleId><ArticleId IdType="pubmed">33383142</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X-N, You Y, Cui X-M, et al. Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients. Sig Transduct Target Ther. 2021;6(1):1&#x2013;11. doi: 10.1038/s41392-021-00753-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00753-7</ArticleId><ArticleId IdType="pmc">PMC8443960</ArticleId><ArticleId IdType="pubmed">34531370</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Gan R, Zhen Z, et al. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals. Sig Transduct Target Ther. 2020;5(1):156. doi: 10.1038/s41392-020-00263-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00263-y</ArticleId><ArticleId IdType="pmc">PMC7426596</ArticleId><ArticleId IdType="pubmed">32796814</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo L, Liang W, Pang J, et al. Dynamics of TCR repertoire and T cell function in COVID-19 convalescent individuals. Cell Discov. 2021;7(1):1&#x2013;17. doi: 10.1038/s41421-021-00321-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00321-x</ArticleId><ArticleId IdType="pmc">PMC8476510</ArticleId><ArticleId IdType="pubmed">34580278</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W, Su W, Tang H, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6(1):31. doi: 10.1038/s41421-020-0168-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-0168-9</ArticleId><ArticleId IdType="pmc">PMC7197635</ArticleId><ArticleId IdType="pubmed">32377375</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai H, Ma J, Mao W, et al. Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing. Blood Cell Mol Dis. 2022;97:102678. doi: 10.1016/j.bcmd.2022.102678</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcmd.2022.102678</ArticleId><ArticleId IdType="pmc">PMC9162783</ArticleId><ArticleId IdType="pubmed">35716403</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X, Chen X, Zhu Y, et al. Single-cell transcriptome landscape and antigen receptor dynamic during SARS-CoV-2 vaccination. Genes &amp; Dis. 2023;10(4):1675&#x2013;1686. doi: 10.1016/j.gendis.2022.08.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gendis.2022.08.020</ArticleId><ArticleId IdType="pmc">PMC9454148</ArticleId><ArticleId IdType="pubmed">36097543</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou X-L, Wang L, Ding Y-L, et al. Current status and recent advances of next generation sequencing techniques in immunological repertoire. Genes Immun. 2016;17(3):153&#x2013;164. doi: 10.1038/gene.2016.9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2016.9</ArticleId><ArticleId IdType="pubmed">26963138</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Paschold L, Simnica D, et al. Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease. Immunity. 2020;53(2):442&#x2013;455.e4. doi: 10.1016/j.immuni.2020.06.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.06.024</ArticleId><ArticleId IdType="pmc">PMC7324317</ArticleId><ArticleId IdType="pubmed">32668194</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou X, Wang G, Fan W, et al. T-cell receptor repertoires as potential diagnostic markers for patients with COVID-19. Int J Infect Dis. 2021;113:308&#x2013;317. doi: 10.1016/j.ijid.2021.10.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.10.033</ArticleId><ArticleId IdType="pmc">PMC8530772</ArticleId><ArticleId IdType="pubmed">34688948</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JJ, Lee KAV, Lam SZ, et al. Machine learning identifies T cell receptor repertoire signatures associated with COVID-19 severity. Commun Biol. 2023;6(1):76. doi: 10.1038/s42003-023-04447-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-023-04447-4</ArticleId><ArticleId IdType="pmc">PMC9853487</ArticleId><ArticleId IdType="pubmed">36670287</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Zhang J, Wang D, et al. Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status. J Autoimmun. 2021;118:102596. doi: 10.1016/j.jaut.2021.102596</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102596</ArticleId><ArticleId IdType="pmc">PMC7837046</ArticleId><ArticleId IdType="pubmed">33540371</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C-M, Feng P-H, Wu T-H, et al. Profiling of T cell repertoire in SARS-CoV-2-infected COVID-19 patients between mild disease and pneumonia. J Clin Immunol. 2021;41(6):1131&#x2013;1145. doi: 10.1007/s10875-021-01045-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01045-z</ArticleId><ArticleId IdType="pmc">PMC8096628</ArticleId><ArticleId IdType="pubmed">33950324</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Wang Y, Jiang S, et al. Comprehensive analysis of TCR repertoire of COVID-19 patients in different infected stage. Genes Genom. 2022;44(7):813&#x2013;822. doi: 10.1007/s13258-022-01261-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13258-022-01261-w</ArticleId><ArticleId IdType="pmc">PMC9107015</ArticleId><ArticleId IdType="pubmed">35567717</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Hu J, Wang Y, et al. T-Cell repertoire characteristics of asymptomatic and Re-detectable positive COVID-19 patients. Front Immunol. 2022;12:769442. doi: 10.3389/fimmu.2021.769442</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.769442</ArticleId><ArticleId IdType="pmc">PMC8828559</ArticleId><ArticleId IdType="pubmed">35154070</ArticleId></ArticleIdList></Reference><Reference><Citation>Assmann JL, Kolijn PM, Schrijver B, et al. TRB sequences targeting ORF1a/b are associated with disease severity in hospitalized COVID-19 patients. J Leukoc Biol. 2021;111(1):283&#x2013;289. doi: 10.1002/JLB.6COVCRA1120-762R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.6COVCRA1120-762R</ArticleId><ArticleId IdType="pmc">PMC8250722</ArticleId><ArticleId IdType="pubmed">33847407</ArticleId></ArticleIdList></Reference><Reference><Citation>Jian X, Zhang Y, Zhao J, et al. CoV2-tcr: a web server for screening TCR CDR3 from TCR immune repertoire of COVID-19 patients and their recognized SARS-CoV-2 epitopes. Comput Struct Biotechnol J. 2023;21:1362&#x2013;1371. doi: 10.1016/j.csbj.2023.01.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2023.01.038</ArticleId><ArticleId IdType="pmc">PMC9882952</ArticleId><ArticleId IdType="pubmed">36741787</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashima Y, Mizutani T, Nakayama-Hosoya K, et al. Multimodal single-cell analyses of peripheral blood mononuclear cells of COVID-19 patients in Japan. Sci Rep. 2023;13(1):1935. doi: 10.1038/s41598-023-28696-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-28696-9</ArticleId><ArticleId IdType="pmc">PMC9893982</ArticleId><ArticleId IdType="pubmed">36732528</ArticleId></ArticleIdList></Reference><Reference><Citation>Gedda MR, Danaher P, Shao L, et al. Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donors. J Transl Med. 2022;20(1):587. doi: 10.1186/s12967-022-03751-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03751-7</ArticleId><ArticleId IdType="pmc">PMC9742656</ArticleId><ArticleId IdType="pubmed">36510222</ArticleId></ArticleIdList></Reference><Reference><Citation>Sureshchandra S, Lewis SA, Doratt BM, et al. Single-cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine. JCI Insight. 2021;6(24):e153201. doi: 10.1172/jci.insight.153201</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.153201</ArticleId><ArticleId IdType="pmc">PMC8783687</ArticleId><ArticleId IdType="pubmed">34935643</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavazovi&#x107; I, Dimitropoulos C, Ga&#x161;parini D, et al. Vaccination provides superior in vivo recall capacity of SARS-CoV-2-specific memory CD8 T cells. Cell Rep. 2023;42(4):112395. doi: 10.1016/j.celrep.2023.112395</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112395</ArticleId><ArticleId IdType="pmc">PMC10070771</ArticleId><ArticleId IdType="pubmed">37099427</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson PA, Padilla M, Hoyland W, et al. AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein&#x2013;specific TH1 response with a diverse TCR repertoire. Sci Transl Med. 2021;13(620):eabj7211. doi: 10.1126/scitranslmed.abj7211</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abj7211</ArticleId><ArticleId IdType="pmc">PMC9924073</ArticleId><ArticleId IdType="pubmed">34591596</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen L, Brokstad KA, Bansal A, et al. Durable immune responses after BNT162b2 vaccination in home-dwelling old adults. Vaccine: x. 2023;13:100262. doi: 10.1016/j.jvacx.2023.100262</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvacx.2023.100262</ArticleId><ArticleId IdType="pmc">PMC9830931</ArticleId><ArticleId IdType="pubmed">36643855</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wang X, Luu LDW, et al. Single&#x2010;cell transcriptomic atlas reveals distinct immunological responses between COVID&#x2010;19 vaccine and natural sars&#x2010;CoV&#x2010;2 infection. J Med Virol. 2022;94(11):5304&#x2013;5324. doi: 10.1002/jmv.28012</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28012</ArticleId><ArticleId IdType="pmc">PMC9350186</ArticleId><ArticleId IdType="pubmed">35859327</ArticleId></ArticleIdList></Reference><Reference><Citation>Armistead B, Jiang Y, Carlson M, et al. Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccination. Mucosal Immunol. 2023;16(1):39&#x2013;49. doi: 10.1016/j.mucimm.2023.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mucimm.2023.01.003</ArticleId><ArticleId IdType="pmc">PMC9836998</ArticleId><ArticleId IdType="pubmed">36642379</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Shin JE, Xu AM, et al. Evidence of premature lymphocyte aging in people with low anti-spike antibody levels after BNT162b2 vaccination. iScience. 2022;25(10):105209. doi: 10.1016/j.isci.2022.105209</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105209</ArticleId><ArticleId IdType="pmc">PMC9510055</ArticleId><ArticleId IdType="pubmed">36188190</ArticleId></ArticleIdList></Reference><Reference><Citation>Henze L, Braun J, Meyer-Arndt L, et al. Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity. Front Immunol. 2023;14:1056525. doi: 10.3389/fimmu.2023.1056525</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1056525</ArticleId><ArticleId IdType="pmc">PMC9927399</ArticleId><ArticleId IdType="pubmed">36798117</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Q, Wu S, Xiao C, et al. Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization. Cell Discov. 2021;7(1):64. doi: 10.1038/s41421-021-00300-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00300-2</ArticleId><ArticleId IdType="pmc">PMC8352953</ArticleId><ArticleId IdType="pubmed">34373443</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcover A, Alarc&#xf3;n B, Di Bartolo V. Cell biology of T cell receptor expression and regulation. Annu Rev Immunol. 2018;36(1):103&#x2013;125. doi: 10.1146/annurev-immunol-042617-053429</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042617-053429</ArticleId><ArticleId IdType="pubmed">29261409</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothenberg EV. Programming for T-lymphocyte fates: modularity and mechanisms. Genes Dev. 2019;33(17&#x2013;18):1117&#x2013;1135. doi: 10.1101/gad.327163.119</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.327163.119</ArticleId><ArticleId IdType="pmc">PMC6719619</ArticleId><ArticleId IdType="pubmed">31481536</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao X, Zhang G, Ma L, et al. Analysis of the CDR3 length of TCR &#x3b1;&#x3b2; T cells in the peripheral blood of patients with chronic hepatitis B. Hepatol Res. 2006;35(1):10&#x2013;18. doi: 10.1016/j.hepres.2006.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hepres.2006.01.006</ArticleId><ArticleId IdType="pubmed">16522377</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Li J, Zhang H, et al. Partial recovery of disturbed V-J pairing profiles of T-cell receptor in people living with HIV receiving long-term antiretroviral therapy. Sci China Life Sci. 2021;64(1):152&#x2013;161. doi: 10.1007/s11427-020-1718-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-020-1718-2</ArticleId><ArticleId IdType="pmc">PMC7306449</ArticleId><ArticleId IdType="pubmed">32567004</ArticleId></ArticleIdList></Reference><Reference><Citation>Sant S, Grzelak L, Wang Z, et al. Single-cell approach to influenza-specific CD8+ T cell receptor repertoires across different age groups, tissues, and following influenza virus infection. Front Immunol. 2018;9:1453. doi: 10.3389/fimmu.2018.01453</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01453</ArticleId><ArticleId IdType="pmc">PMC6030351</ArticleId><ArticleId IdType="pubmed">29997621</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Wang X, Xing X, et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat Immunol. 2020;21(9):1107&#x2013;1118. doi: 10.1038/s41590-020-0762-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0762-x</ArticleId><ArticleId IdType="pubmed">32788748</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao XS, Diao Y, Sun WB, et al. Analysis of the CDR3 length repertoire and the diversity of TCR alpha chain in human peripheral blood T lymphocytes. Cell Mol Immunol. 2007;4(3):215&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">17601376</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao X, Ma L, Wen X, et al. Establishment and identification of immune scanning spectrum analysis technique for monitoring TCR CDR3 drift. Chin J Microbiol Immunol. 2006;6:571&#x2013;573.</Citation></Reference><Reference><Citation>Ruiz Ortega M, Spisak N, Mora T, et al. Modeling and predicting the overlap of B- and T-cell receptor repertoires in healthy and SARS-CoV-2 infected individuals. Cameron MJ, editor. PLOS Genet. 2023;19(2):e1010652. doi: 10.1371/journal.pgen.1010652</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1010652</ArticleId><ArticleId IdType="pmc">PMC10075420</ArticleId><ArticleId IdType="pubmed">36827454</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L, Guan Y. Immunologic basis for long HCDR3s in broadly neutralizing antibodies against HIV-1. Front Immunol. 2014;5:250. doi: 10.3389/fimmu.2014.00250</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00250</ArticleId><ArticleId IdType="pmc">PMC4040451</ArticleId><ArticleId IdType="pubmed">24917864</ArticleId></ArticleIdList></Reference><Reference><Citation>Minervina AA, Komech EA, Titov A, et al. Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection. Elife. 2021;10:e63502. doi: 10.7554/eLife.63502</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.63502</ArticleId><ArticleId IdType="pmc">PMC7806265</ArticleId><ArticleId IdType="pubmed">33399535</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong R, Luo L, Zhao Y, et al. Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing. Emerg Microbes Infec. 2023;12(1):e2187245. doi: 10.1080/22221751.2023.2187245</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2187245</ArticleId><ArticleId IdType="pmc">PMC10171127</ArticleId><ArticleId IdType="pubmed">36987861</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Shi Y, Gong B, et al. Dynamic blood single-cell immune responses in patients with COVID-19. Sig Transduct Target Ther. 2021;6(1):110. doi: 10.1038/s41392-021-00526-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00526-2</ArticleId><ArticleId IdType="pmc">PMC7936231</ArticleId><ArticleId IdType="pubmed">33677468</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgakilas GK, Galanopoulos AP, Tsinaris Z, et al. Machine-learning-assisted analysis of TCR profiling data unveils cross-reactivity between SARS-CoV-2 and a wide spectrum of pathogens and other diseases. Biology (Basel). 2022;11(10):1531. doi: 10.3390/biology11101531</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology11101531</ArticleId><ArticleId IdType="pmc">PMC9598299</ArticleId><ArticleId IdType="pubmed">36290433</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowntree LC, Nguyen THO, Kedzierski L, et al. SARS-CoV-2-specific T cell memory with common TCR&#x3b1;&#x3b2; motifs is established in unvaccinated children who seroconvert after infection. Immunity. 2022;55(7):1299&#x2013;1315.e4. doi: 10.1016/j.immuni.2022.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.06.003</ArticleId><ArticleId IdType="pmc">PMC9174177</ArticleId><ArticleId IdType="pubmed">35750048</ArticleId></ArticleIdList></Reference><Reference><Citation>Minervina AA, Pogorelyy MV, Kirk AM, et al. SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells. Nat Immunol. 2022;23(5):781&#x2013;790. doi: 10.1038/s41590-022-01184-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01184-4</ArticleId><ArticleId IdType="pmc">PMC9106845</ArticleId><ArticleId IdType="pubmed">35383307</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren C, Ji R, Li Y, et al. Longitudinal change trend of the TCR repertoire reveals the immune response intensity of the inactivated COVID-19 vaccine. Mol Immunol. 2023;163:39&#x2013;47. doi: 10.1016/j.molimm.2023.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2023.09.006</ArticleId><ArticleId IdType="pubmed">37738878</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford ES, Mayer-Blackwell K, Jing L, et al. Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19. Nat Immunol. 2024;25(1):166&#x2013;177. doi: 10.1038/s41590-023-01692-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01692-x</ArticleId><ArticleId IdType="pmc">PMC10981451</ArticleId><ArticleId IdType="pubmed">38057617</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaisawangwong W, Wang H, Kouo T, et al. Cross-reactivity of SARS-CoV-2- and influenza A-specific T cells in individuals exposed to SARS-CoV-2. JCI Insight. 2022;7(18):e158308. doi: 10.1038/s41590-023-01692-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01692-x</ArticleId><ArticleId IdType="pmc">PMC9675569</ArticleId><ArticleId IdType="pubmed">36134660</ArticleId></ArticleIdList></Reference><Reference><Citation>Loyal L, Braun J, Henze L, et al. Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination. Science. 2021;374(6564):eabh1823. doi: 10.1126/science.abh1823</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abh1823</ArticleId><ArticleId IdType="pmc">PMC10026850</ArticleId><ArticleId IdType="pubmed">34465633</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S-Y, Yue T, Lei Q, et al. Tcrdb: a comprehensive database for T-cell receptor sequences with powerful search function. Nucleic Acids Res. 2021;49(D1):D468&#x2013;D474. doi: 10.1093/nar/gkaa796</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa796</ArticleId><ArticleId IdType="pmc">PMC7778924</ArticleId><ArticleId IdType="pubmed">32990749</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncharov M, Bagaev D, Shcherbinin D, et al. Vdjdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2. Nat Methods. 2022;19(9):1017&#x2013;1019. doi: 10.1038/s41592-022-01578-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-022-01578-0</ArticleId><ArticleId IdType="pubmed">35970936</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan S, Vignali M, Klinger M, et al. A large-scale database of T-cell receptor beta (TCR&#x3b2;) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2. Res Sq. 2020:rs.3.rs&#x2013;51964. doi: 10.21203/rs.3.rs-51964/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-51964/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Chronister W, Crinklaw A, Mahajan S, et al. Tcrmatch: predicting T-Cell receptor specificity based on sequence similarity to Previously characterized receptors. Front Immunol. 2021;12:640725. doi: 10.3389/fimmu.2021.640725</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.640725</ArticleId><ArticleId IdType="pmc">PMC7991084</ArticleId><ArticleId IdType="pubmed">33777034</ArticleId></ArticleIdList></Reference><Reference><Citation>Gielis S, Moris P, Bittremieux W, et al. Detection of enriched T cell epitope specificity in full T cell receptor sequence repertoires. Front Immunol. 2019;10:2820. doi: 10.3389/fimmu.2019.02820</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02820</ArticleId><ArticleId IdType="pmc">PMC6896208</ArticleId><ArticleId IdType="pubmed">31849987</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan S, Vita R, Shackelford D, et al. Epitope specific antibodies and T cell receptors in the immune epitope database. Front Immunol. 2018;9:2688. doi: 10.3389/fimmu.2018.02688</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02688</ArticleId><ArticleId IdType="pmc">PMC6255941</ArticleId><ArticleId IdType="pubmed">30515166</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>